15th International Workshop on Women & HIV 2025

The 15th International Workshop on Women & HIV took place in a hybrid format on 4-5 April 2025 in Barcelona, Spain.

1. The rates of HIV infection in women continue to increase, and the numbers are impacted by migration, extreme weather events, resource insecurities, and program interruptions.
2. Breastfeeding policies for women living with HIV continue to evolve, and strategies to enable women to breastfeed safely are evolving.
3. Women living with HIV are at increased risk of cardiovascular disease, and the risk models designed for persons without HIV infection do not always apply. Statins have been shown to decrease cardiovascular events, especially in those over 40 years and with other risk factors.
4. Injectable antiretroviral agents for treatment and prevention are adding an important choice for women living with and at risk for HIV. Challenges regarding access need to be addressed.
5. Management of women with HIV needs to extend beyond antiretroviral therapy to include coinfection (HPV) and co-morbidities (liver disease and cognitive function).
6. We need to continue to ensure women are aware of the value of clinical trials and how their contribution advances the field

The 16th International Workshop on Women & HIV 2026 will take place on 10-11 April 2026 in Europe (TBC).

The International Workshop on Women & HIV has now completed its 15th year and continues to evolve. It is an outstanding opportunity for healthcare providers, researchers, government, industry, and community representatives to discuss, debate, and further their knowledge on the issues related to HIV and women.

The format of the workshop enables attendees to learn from world-leading HIV experts and discuss the issues, gaps, and opportunities for further learning and research. Many of the attendees continue to participate each year and have formed valuable relationships and partnerships that have led to collaborative projects.

The enthusiasm and dedication of the participants is palpable throughout the workshop. The debates and roundtables are an important vehicle to discuss the issues and challenge dogmas.

Over the years, the number and quality of submitted abstracts have continued to improve. The workshop also provides a forum for early-career investigators to present their work and to personally meet with experts they view as mentors and inspirations for their work. The workshop considers both local and global issues and the information learnt in one setting is often translated into another.

We encourage you to consider joining us in 2026! 

On behalf of the Organizing Committee

General Information 

Practical Information 

The members of the Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

• Karoline Aebi-Popp, PD, MD, MSc, University Hospital Bern, Switzerland
• Sergii Antoniak, MD, Gromashevsky Institute of Epidemiology and Infectious Diseases, National Academy of Medical Sciences of Ukraine, Ukraine
• Dawn Averitt, The Well Project/WRI, United States
• Olga Belyaeva, Eurasian Network of People who Use Drugs (ENPUD), Ukraine
• Marina Bobkova, MD, PhD, Gamaleya Center for Epidemiology and Microbiology, Russian Ministry of Health, Russia                     
• Claudia Cortes, MD, University of Chile, Chile
• Dazon Dixon Diallo, MPH, Sister Love, United States
• Mirjam-Colette Kempf, MD, MPH, University of Alabama at Birmingham, United States
• Justyna Kowalska, MD, PhD, Hospital for Infectious Diseases, Poland
• Allen Kyendikuwa, BA, Uganda Youth Coalition on Adolescent SRHR and HIV (CYSRA), Uganda
• Mona Loutfy, MD, FRCPC, MPH, Women's College Research Institute (Univ. Toronto), Canada
• Mariana Mardarescu, MD, PhD, National Institute for Infectious Diseases "Prof. Dr. Matei Bals", Romania
• Catia Marzolini, PharmD, PhD, University Hospital Basel, Switzerland
• Deborah Money, MD, FRCSC, University of British Columbia, Canada
• Teresia Otieno, ATHENA Network, United States
• Lena Serghides, PhD, University Health Network, Canada
• William R. Short, MD, MPH, FIDSA, University of Pennsylvania, United States
• Shema Tariq, PhD, FRCP, University College London, United Kingdom
• Patricia Vasquez, MD, Hospital San Juan de Dios, Chile
• Marta Vasylyev, MD, Astar Medical Center, Ukraine
• Markella Zanni, MD, MGH/Harvard Medical School, United States

Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals, researchers, and community representatives involved in the International Workshop on Women & HIV 2025.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
 
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Lara da Silva Miguel at Lara@amededu.com.
 
Benefits of Support 
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

• Symposium opportunities
• Non-commercial interviews with company representatives
• Verbal acknowledgment during the program 
• Discounted and complimentary registrations for your representatives
• Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
• Company acknowledgment on printed meeting materials including but not limited to banners and the program book
• Digital and printed advertising opportunities 
• Social media shout-outs
• Logo on the conference bag 

 
*Subject to the support level

• 14th Edition - International Workshop on HIV & Women 2024, United States (Hybrid)
• 13th Edition - International Workshop on HIV & Women 2023, United States (Hybrid)
• 12th Edition - International Workshop on HIV & Women 2022, Virtual
• 11th Edition - International Workshop on HIV & Women 2021, Virtual
• 10th Edition - International Workshop on HIV & Women 2020, United States
• 9th Edition - International Workshop on HIV & Women 2019, United States

The International Workshop on Women & HIV 2025, Barcelona, Spain 04/04/2025 - 05/04/2025 , has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 10.5 European CME credits (ECMEC®s).
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications .

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.